Literature DB >> 22553243

First report of vancomycin-intermediate resistance in sequence type 72 community genotype methicillin-resistant Staphylococcus aureus.

Doo Ryeon Chung1, Jin Yang Baek, Hyun Ah Kim, Min Hee Lim, So Hyun Kim, Kwan Soo Ko, Cheol-In Kang, Kyong Ran Peck, Nam Yong Lee, Jae-Hoon Song.   

Abstract

Vancomycin-intermediate resistance has not been previously reported among sequence type 72 (ST72) methicillin-resistant Staphylococcus aureus (MRSA) isolates of SCCmec type IV (ST72-MRSA-IV), which are distinctive community genotype strains in Korea. We report the first case of vancomycin treatment failure due to development of vancomycin-intermediate resistance in infection caused by an ST72-MRSA-IV isolate.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22553243      PMCID： PMC3405585          DOI： 10.1128/JCM.00590-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Hermínia de Lencastre
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

Authors:  Longzhu Cui; Akira Iwamoto; Jian-Qi Lian; Hui-min Neoh; Toshiki Maruyama; Yataro Horikawa; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation.

Authors:  Chulmin Park; Na-Young Shin; Ji-Hyun Byun; Hyun-Ho Shin; Eun-Young Kwon; Su-Mi Choi; Si-Hyun Kim; Jae-Chul Kwon; Sun Hee Park; Jung-Hyun Choi; Jin-Hong Yoo; Jae Il Yoo; Gyung Tae Chung; Dong-Gun Lee
Journal:  J Med Microbiol       Date:  2011-10-20       Impact factor: 2.472

4.  Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Authors:  K Hiramatsu; H Hanaki; T Ino; K Yabuta; T Oguri; F C Tenover
Journal:  J Antimicrob Chemother       Date:  1997-07       Impact factor: 5.790

5.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

6.  Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus.

Authors:  Jeffrey C Hageman; Jean Patel; Patrick Franklin; Karen Miscavish; Linda McDougal; David Lonsway; Fazle N Khan
Journal:  Diagn Microbiol Infect Dis       Date:  2008-10-07       Impact factor: 2.803

7.  Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Authors:  Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

Authors:  Scott K Fridkin; Jeff Hageman; Linda K McDougal; Jasmine Mohammed; William R Jarvis; Trish M Perl; Fred C Tenover
Journal:  Clin Infect Dis       Date:  2003-01-31       Impact factor: 9.079

9.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.

Authors:  M C Enright; N P Day; C E Davies; S J Peacock; B G Spratt
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

10.  Intermediate vancomycin susceptibility in a community-associated MRSA clone.

Authors:  Christopher J Graber; Margaret K Wong; Heather A Carleton; Françoise Perdreau-Remington; Barbara L Haller; Henry F Chambers
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883
View more
  3 in total

1.  First case report of vancomycin-intermediate sequence type 72 Staphylococcus aureus with nonsusceptibility to daptomycin.

Authors:  Ayaka Tsukimori; Itaru Nakamura; Sakiko Okamura; Akihiro Sato; Shinji Fukushima; Yasutaka Mizuno; Tetsuo Yamaguchi; Tetsuya Matsumoto
Journal:  BMC Infect Dis       Date:  2014-08-23       Impact factor: 3.090

2.  Genome-Wide Analysis of Staphylococcus aureus Sequence Type 72 Isolates Provides Insights Into Resistance Against Antimicrobial Agents and Virulence Potential.

Authors:  Nayab Batool; Amen Shamim; Akhilesh Kumar Chaurasia; Kyeong Kyu Kim
Journal:  Front Microbiol       Date:  2021-01-20       Impact factor: 5.640

3.  Novel vancomycin-peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus.

Authors:  Pavlina Jelinkova; Zbynek Splichal; Ana Maria Jimenez Jimenez; Yazan Haddad; Aninda Mazumdar; Vishma Pratap Sur; Vedran Milosavljevic; Pavel Kopel; Hana Buchtelova; Roman Guran; Ondrej Zitka; Lukas Richtera; Dagmar Hegerova; Zbynek Heger; Amitava Moulick; Vojtech Adam
Journal:  Infect Drug Resist       Date:  2018-10-12       Impact factor: 4.003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.